Cargando…

Validation of an obstetric comorbidity index in an external population

OBJECTIVES: An obstetric comorbidity index has been developed recently with superior performance characteristics relative to general comorbidity measures in an obstetric population. This study aimed to externally validate this index and to examine the impact of including hospitalisation/delivery rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Metcalfe, A, Lix, LM, Johnson, J‐A, Currie, G, Lyon, AW, Bernier, F, Tough, SC
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006847/
https://www.ncbi.nlm.nih.gov/pubmed/25559311
http://dx.doi.org/10.1111/1471-0528.13254
_version_ 1782451135335890944
author Metcalfe, A
Lix, LM
Johnson, J‐A
Currie, G
Lyon, AW
Bernier, F
Tough, SC
author_facet Metcalfe, A
Lix, LM
Johnson, J‐A
Currie, G
Lyon, AW
Bernier, F
Tough, SC
author_sort Metcalfe, A
collection PubMed
description OBJECTIVES: An obstetric comorbidity index has been developed recently with superior performance characteristics relative to general comorbidity measures in an obstetric population. This study aimed to externally validate this index and to examine the impact of including hospitalisation/delivery records only when estimating comorbidity prevalence and discriminative performance of the obstetric comorbidity index. DESIGN: Validation study. SETTING: Alberta, Canada. POPULATION: Pregnant women who delivered a live or stillborn infant in hospital (n = 5995). METHODS: Administrative databases were linked to create a population‐based cohort. Comorbid conditions were identified from diagnoses for the delivery hospitalisation, all hospitalisations and all healthcare contacts (i.e. hospitalisations, emergency room visits and physician visits) that occurred during pregnancy and 3 months pre‐conception. Logistic regression was used to test the discriminative performance of the comorbidity index. MAIN OUTCOME MEASURES: Maternal end‐organ damage and extended length of stay for delivery. RESULTS: Although prevalence estimates for comorbid conditions were consistently lower in delivery records and hospitalisation data than in data for all healthcare contacts, the discriminative performance of the comorbidity index was constant for maternal end‐organ damage [all healthcare contacts area under the receiver operating characteristic curve (AUC) = 0.70; hospitalisation data AUC = 0.67; delivery data AUC = 0.65] and extended length of stay for delivery (all healthcare contacts AUC = 0.60; hospitalisation data AUC = 0.58; delivery data AUC = 0.58). CONCLUSIONS: The obstetric comorbidity index shows similar performance characteristics in an external population and is a valid measure of comorbidity in an obstetric population. Furthermore, the discriminative performance of the comorbidity index was similar for comorbidities ascertained at the time of delivery, in hospitalisation data or through all healthcare contacts.
format Online
Article
Text
id pubmed-5006847
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-50068472016-09-16 Validation of an obstetric comorbidity index in an external population Metcalfe, A Lix, LM Johnson, J‐A Currie, G Lyon, AW Bernier, F Tough, SC BJOG Epidemiology OBJECTIVES: An obstetric comorbidity index has been developed recently with superior performance characteristics relative to general comorbidity measures in an obstetric population. This study aimed to externally validate this index and to examine the impact of including hospitalisation/delivery records only when estimating comorbidity prevalence and discriminative performance of the obstetric comorbidity index. DESIGN: Validation study. SETTING: Alberta, Canada. POPULATION: Pregnant women who delivered a live or stillborn infant in hospital (n = 5995). METHODS: Administrative databases were linked to create a population‐based cohort. Comorbid conditions were identified from diagnoses for the delivery hospitalisation, all hospitalisations and all healthcare contacts (i.e. hospitalisations, emergency room visits and physician visits) that occurred during pregnancy and 3 months pre‐conception. Logistic regression was used to test the discriminative performance of the comorbidity index. MAIN OUTCOME MEASURES: Maternal end‐organ damage and extended length of stay for delivery. RESULTS: Although prevalence estimates for comorbid conditions were consistently lower in delivery records and hospitalisation data than in data for all healthcare contacts, the discriminative performance of the comorbidity index was constant for maternal end‐organ damage [all healthcare contacts area under the receiver operating characteristic curve (AUC) = 0.70; hospitalisation data AUC = 0.67; delivery data AUC = 0.65] and extended length of stay for delivery (all healthcare contacts AUC = 0.60; hospitalisation data AUC = 0.58; delivery data AUC = 0.58). CONCLUSIONS: The obstetric comorbidity index shows similar performance characteristics in an external population and is a valid measure of comorbidity in an obstetric population. Furthermore, the discriminative performance of the comorbidity index was similar for comorbidities ascertained at the time of delivery, in hospitalisation data or through all healthcare contacts. John Wiley and Sons Inc. 2015-01-05 2015-12 /pmc/articles/PMC5006847/ /pubmed/25559311 http://dx.doi.org/10.1111/1471-0528.13254 Text en © 2015 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Epidemiology
Metcalfe, A
Lix, LM
Johnson, J‐A
Currie, G
Lyon, AW
Bernier, F
Tough, SC
Validation of an obstetric comorbidity index in an external population
title Validation of an obstetric comorbidity index in an external population
title_full Validation of an obstetric comorbidity index in an external population
title_fullStr Validation of an obstetric comorbidity index in an external population
title_full_unstemmed Validation of an obstetric comorbidity index in an external population
title_short Validation of an obstetric comorbidity index in an external population
title_sort validation of an obstetric comorbidity index in an external population
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5006847/
https://www.ncbi.nlm.nih.gov/pubmed/25559311
http://dx.doi.org/10.1111/1471-0528.13254
work_keys_str_mv AT metcalfea validationofanobstetriccomorbidityindexinanexternalpopulation
AT lixlm validationofanobstetriccomorbidityindexinanexternalpopulation
AT johnsonja validationofanobstetriccomorbidityindexinanexternalpopulation
AT currieg validationofanobstetriccomorbidityindexinanexternalpopulation
AT lyonaw validationofanobstetriccomorbidityindexinanexternalpopulation
AT bernierf validationofanobstetriccomorbidityindexinanexternalpopulation
AT toughsc validationofanobstetriccomorbidityindexinanexternalpopulation